Dear All, I am deeply saddened to hear this news. During my PhD in Minnesota, I had the privilege of engaging with Dr. Ludden through Skype interactions. In the advanced PK course taught by Dr. Bill Elmquist, we had a unique assignment to write an essay on the scientific impact and life journey of a notable scientist in the field of Pharmacometrics. I don't recall how I chose Dr. Ludden, but he was incredibly welcoming and generously shared numerous stories about his personal and professional experiences. I cherish those conversations and the insights he provided. I hope to find this essay in one of my emails, and if I do, I will share it with you
Rest in peace, Dr. Ludden. Warm regards, Vijay On Mon, Aug 5, 2024 at 4:49 PM Rene Bruno <rbruno...@gmail.com> wrote: > Dear all, > > This is indeed very sad. I concur with everyone. Ton was a very nice > person, always open to listen to you and provide advice and support. II met > with him a couple of times in the early 90ies and particularly in one > formal meeting (probably in 1992) when he was heading Pharmacometry at FDA. > He has been so supportive to my popPK/PD plans to support the filing of > docetaxel (Taxotere) that when I got back in my company (Rhone Poulenc, now > Sanofi) that the SVP of Regulatory asked me "what it is that you are doing? > population PK???? Given such positive feedback from Tom (and FDA) I got > full support to get the data and analysis done on time for the filing. > Tom's support changed my life as well as the one of patients > receiving Taxotere with the Boxed Warning about elevated hepatic enzymes > (still in the US PI) and the dose adjustment in the EU SCP. > > I will be indebted to him forever. > > René > > > <https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail> > Sans > virus.www.avast.com > <https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=webmail> > <#m_-7736047338385682954_DAB4FAD8-2DD7-40BB-A1B8-4E2AA1F9FDF2> > > Le ven. 2 août 2024 à 20:56, Riley, Steve <steve.ri...@pfizer.com> a > écrit : > >> Dear NM-Users, >> >> >> >> Regrettably, I am writing to let you know that Dr. Ludden passed away >> Tuesday evening, 30JUL2024. >> >> I was able to get there over the weekend prior to visit him and his >> family. >> >> During his wakeful moments we had some good scientific discussions. >> >> We talked a lot about NONMEM and how its functionality and utility has >> expanded since he retired. He was pleased to hear about the changes. >> >> He was surrounded by family for the days leading up to the end. They were >> all appreciative that I was able to get there and tell him (and them) how >> much he meant to all of us and the impact he had on our careers. >> >> >> >> I think memories of Dr. Ludden were characterized perfectly by Marc >> Gastonguay, “I am forever grateful for the positive impact that Tom had on >> my life and career, not to mention the tremendous, although often >> underappreciated, contributions he made to the disciplines of clinical >> pharmacology and pharmacometrics. His humble brilliance will be missed and >> fondly remembered.” >> >> >> Steve Riley >> >> >> > -- ~Vijay